Spectinomycin is primarily a bacteriostatic antibiotic that inhibits protein synthesis in susceptible bacteria by binding to the 30S ribosomal subunit. Spectinomycin has activity against a wide variety of grampositive and gram-negative bacteria, including _E. coli_, Klebsiella, Proteus, Enterobacter, Salmonella, Streptococci, Staphylococcus, and Mycoplasma. It has minimal activity against anaerobes, most strains of Pseudomonas, Chlamydia, or Treponema. In human medicine, spectinomycin is used principally for its activity against _Neisseria gonorrhoeae_ .
Spironolactone may be used in patients with congestive heart failure who do not adequately respond to furosemide and ACE inhibitors, who develop hypokalemia on other diuretics, and are unwilling or unable to supplement with exogenous potassium sources. It may also be effective in treating ascites as it has less potential to increase ammonia levels than other diuretics.
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
現行資料混合 HCl 與 sulfate、口服液／注射液／飲水粉、犬貓馬等舊方案、截斷禽鳥文字及多個食用動物法域；25 張數值卡沒有任何一張能在通用 API 同時閉合精確產品、鹽型、濃度、物種／生命階段、途徑、適應症／藥敏、法域、停藥期與監測。
DRUGAPI 劑量審查引用的獸醫官方標示（各標示只適用於其產品、物種與法域，不可互換）
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。
90-100%
5 hours